Antibody-based molecular imaging agent offers hope for novel breast cancer treatments
For years researchers have been developing molecular imaging techniques that visualize hormonally active breast cancer cells-specifically those testing positive for human epidermal growth factor receptor 2 (HER2).
Linear Mode
